Target intelligence / Profile preview

30S prokaryotic ribosomal subunit (30S subunit) (30S subunit)

Target
30S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The 30S prokaryotic ribosomal subunit is the smaller component of the 70S bacterial ribosome, consisting of a 16S ribosomal RNA (rRNA) strand and approximately 21 distinct ribosomal proteins [2]. It serves a fundamental role in the initiation of protein synthesis and the decoding of genetic information by ensuring accurate base-pairing between mRNA codons and tRNA anticodons [2]. Because of its essential nature and structural divergence from the eukaryotic 40S subunit, it is a primary target for diverse antibiotic classes, including aminoglycosides, tetracyclines, and spectinomycin [1, 3]. These drugs bind to specific pockets within the subunit to disrupt the translation process, effectively treating a wide range of bacterial infections [1]. However, the clinical use of 30S-targeting drugs is often complicated by the development of bacterial resistance mechanisms, such as ribosomal protection proteins or enzymatic modification of the rRNA, and potential host toxicities like damage to the kidneys or inner ear [1, 3].

Other names
Small ribosomal subunitBacterial 30S ribosome30S ribosomal subunit
02

Mechanism of action

Antibiotics targeting the 30S subunit inhibit protein synthesis through various mechanisms: aminoglycosides bind to the 16S rRNA A-site to cause mRNA misreading and translocation inhibition [1], while tetracyclines sterically block the A-site to prevent aminoacyl-tRNA binding [3].

03

Biological functions

Protein synthesisTranslation initiationmRNA decodingGenetic code translation
04

Disease associations

InfectionBacterial infection
05

Safety considerations

Nephrotoxicity [1]Ototoxicity [1]Neuromuscular blockadeAntibiotic resistanceGastrointestinal distress
06

Interacting drugs

Gentamicin

11 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Bacterial load16S rRNA methyltransferase expression

Beyond the preview

Go deeper on 30S prokaryotic ribosomal subunit (30S subunit) (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 30S prokaryotic ribosomal subunit (30S subunit) (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call